Form 4 for HIND Vyome Holdings, Inc
Accepted 2021-09-17 00:00:00 ET · period of report 2021-07-22 · accession 0001790300-21-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-17 | 2021-07-22 | HIND | GLADNEY DAN W | Dir | A - Grant | $0.00 | +483.9K | 483.9K | New | $0 | |
| 2021-09-17 | 2021-09-10 | HIND | GLADNEY DAN W | Dir | S - Sale | $2.99 | -200.0K | 283.9K | -41% | -$598.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.001 par value per share | 2021-07-22 | A | A | 483,922 | $0.00 | 483,922 | D | — | — | (F1) These shares will vest and be issued with respect to 241,961 shares on each of July 22, 2021 and July 22, 2022 pursuant to a restricted stock unit granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan. |
| 2 | Common | Common Stock, $0.001 par value per share | 2021-09-10 | S | D | 200,000 | $2.99 | 283,922 | D | — | — |